Recently, there have been many findings linking GLO1 to CNS degenerative diseases, hypertension, ageing, epigenetics, diabetes-related neurological complications, and several behavioural phenotypes (Figure 3). This evidence concerns the gene GLO1 and diabetes mellitus.